Target Name: OPN4
NCBI ID: G94233
Review Report on OPN4 Target / Biomarker Content of Review Report on OPN4 Target / Biomarker
OPN4
Other Name(s): Melanopsin | OPN4_HUMAN | Opsin-4 | Melanopsin (isoform 1) | OPN4 variant 1 | Opsin 4, transcript variant 1 | MOP | opsin 4

OPN4: A Potential Drug Target for Photoreceptor Cell Functional Disorders

OPN4, also known as Melanopsin, is a protein that is expressed in the retina of the eye. It is a member of the superfamily of G-coupled proteins, which are a type of transmembrane protein that consists of a catalytic center and a cytoplasmic tail. OPN4 is involved in the process of intracellular signaling, which is the process by which cells communicate with one another.

One of the functions of OPN4 is to regulate the production of melanin, which is the pigment that gives the color to the skin, hair, and eyes. Melanin is produced by melanocytes, which are specialized cells that are responsible for producing the pigment. In the retina, melanin is important for the structure and function of the retina, including the development and maintenance of the retina's photoreceptor cells.

In addition to its role in regulating melanin production, OPN4 is also involved in the process of photoreceptor cell signaling. Photoreceptor cells are specialized cells that are responsible for detecting light and transmitting signals to the brain. They are located in the retina and are sensitive to changes in light intensity.

OPN4 has been shown to play a role in the regulation of photoreceptor cell signaling by interacting with a protein called TRPML1. TRPML1 is a protein that is expressed in the photoreceptor cells and is involved in the regulation of light sensitivity. OPN4 has been shown to physically interact with TRPML1 and to regulate the production of melanin in photoreceptor cells.

This suggests that OPN4 may be a drug target or biomarker for the treatment of conditions related to photoreceptor cell dysfunction, such as age-related macular degeneration (AMD), which is a progressive eye disease that is characterized by the gradual loss of photoreceptor cells.

In addition to its potential as a drug target or biomarker, OPN4 is also of interest as a potential therapeutic agent for other conditions. For example, OPN4 has been shown to have anti-inflammatory properties and to protect against oxidative stress in photoreceptor cells. This suggests that OPN4 may be a useful agent for the treatment of conditions that involve inflammation or oxidative stress, such as optic neuritis or diabetic retinopathy.

Overall, OPN4 is a protein that is expressed in the retina and is involved in the regulation of melanin production and photoreceptor cell signaling. Its potential as a drug target or biomarker for the treatment of photoreceptor cell dysfunction and other conditions makes it an attractive target for further research.

Protein Name: Opsin 4

Functions: Photoreceptor that binds cis-retinaldehydes (PubMed:15674244). Contributes to pupillar reflex, photoentrainment and other non-image forming responses to light (By similarity). May be involved in the optokinetic visual tracking response (By similarity). May be involved in the regulation of retinal hyaloid vessel growth and regression (By similarity)

The "OPN4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OPN4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

OPN5 | OPRD1 | OPRK1 | OPRL1 | OPRM1 | OPRPN | OPTC | OPTN | OR10A2 | OR10A3 | OR10A4 | OR10A5 | OR10A6 | OR10A7 | OR10AA1P | OR10AB1P | OR10AC1 | OR10AD1 | OR10AF1P | OR10AG1 | OR10AK1P | OR10C1 | OR10D1P | OR10D3 | OR10D4P | OR10G2 | OR10G3 | OR10G4 | OR10G7 | OR10G8 | OR10G9 | OR10H1 | OR10H2 | OR10H3 | OR10H4 | OR10H5 | OR10J1 | OR10J2P | OR10J3 | OR10J5 | OR10K1 | OR10K2 | OR10P1 | OR10Q1 | OR10R2 | OR10S1 | OR10T2 | OR10V1 | OR10W1 | OR10X1 | OR10Z1 | OR11A1 | OR11G2 | OR11H1 | OR11H12 | OR11H13P | OR11H2 | OR11H5P | OR11H6 | OR11H7 | OR11J2P | OR11J5P | OR11K2P | OR11L1 | OR11M1P | OR12D2 | OR12D3 | OR13A1 | OR13C2 | OR13C3 | OR13C4 | OR13C5 | OR13C8 | OR13C9 | OR13D1 | OR13F1 | OR13G1 | OR13H1 | OR13J1 | OR13Z2P | OR14A16 | OR14A2 | OR14C36 | OR14I1 | OR14J1 | OR14L1P | OR1A1 | OR1A2 | OR1B1 | OR1C1 | OR1D2 | OR1D4 | OR1D5 | OR1E1 | OR1E2 | OR1E3 | OR1F1 | OR1F2P | OR1G1 | OR1I1